MDPI and ACS Style
Mihimit, A.; Adawaye, C.; Péré, H.; Costiniuk, C.; Koyalta, D.; Mbopi-Keou, F.-X.; Bouassa, R.-S.M.; Talla, F.; Moussa, S.; Longo, J.D.D.;
et al. HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon. Trop. Med. Infect. Dis. 2020, 5, 136.
https://doi.org/10.3390/tropicalmed5030136
AMA Style
Mihimit A, Adawaye C, Péré H, Costiniuk C, Koyalta D, Mbopi-Keou F-X, Bouassa R-SM, Talla F, Moussa S, Longo JDD,
et al. HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon. Tropical Medicine and Infectious Disease. 2020; 5(3):136.
https://doi.org/10.3390/tropicalmed5030136
Chicago/Turabian Style
Mihimit, Abdoulaye, Chatté Adawaye, Hélène Péré, Cecilia Costiniuk, Donato Koyalta, François-Xavier Mbopi-Keou, Ralph-Sydney Mboumba Bouassa, Frédéric Talla, Sandrine Moussa, Jean De Dieu Longo,
and et al. 2020. "HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon" Tropical Medicine and Infectious Disease 5, no. 3: 136.
https://doi.org/10.3390/tropicalmed5030136
